Table 1 Baseline characteristics and results of the sample of patients that performed the virtual reality dichoptic training using the Oculus Rift virtual reality head mounted display
Patient | Healthy eye (Dsph. Dcyl) | Amblyopic eye (Dsph. Dcyl) | BCVA -before DT | BCVA -after DT | Stereoacuity -before DT | Stereoacuity -after DT | ||
|---|---|---|---|---|---|---|---|---|
1 | +0.5 | +1 | −0.5 | +3.50 | 0.9 | 0.9 | nil | nil |
2 | +0.75 | +1.5 | +2.37 | +0.75 | 1.3 | 1.3 | nil | 400 |
3 | +0.25 | +0.5 | +4.5 | +2.5 | 0.5 | 0.4 | nil | 140 |
4 | −2.5 | +1 | −3.5 | +1 | 0.6 | 0.5 | nil | 50 |
5 | +0.50 | 0 | +7.00 | +0.5 | 0.4 | 0.3 | 400 | 400 |
6 | +2 | +0.5 | +3.00 | +1.0 | 0.4 | 0.3 | 200 | 200 |
7 | −0.12 | +0.75 | +1.5 | +1.0 | 0.1 | 0.0 | 70 | 50 |
8 | +0.25 | +0.5 | +3.00 | +0.5 | 0.2 | 0.1 | 140 | 20 |
9 | +0.75 | 0 | +3.75 | +0.5 | 0.2 | 0.0 | 400 | 160 |
10 | +0.25 | +0.5 | +1.00 | +1.5 | 0.3 | 0.0 | 200 | 20 |
11 | +0.5 | +0.5 | +4.25 | +1.0 | 0.5 | 0.4 | 400 | 140 |
12 | +0.50 | 0 | +2.25 | +1.5 | 0.5 | 0.4 | nil | 400 |
13 | +0.25 | 0 | +1.75 | +3.0 | 1.0 | 0.5 | niI | 400 |
14 | +0.5 | +1.0 | +2.50 | 0 | 0.3 | 0.3 | 400 | 50 |
15 | +0.5 | +0.5 | +4.0 | +1.0 | 0.5 | 0.1 | 160 | 20 |
16 | −8.0 | +1.0 | −12.0 | +2 | 1.0 | 0.7 | nil | nil |
17 | 0 | 0 | +1.87 | +0.75 | 1.1 | 1.1 | nil | 200 |